IMR90 cells, HPrEC and NSC were transfected with 20-30 nM siRNA (Qiagen), miR or anti-miR (Ambion) in 96-well or 6-well plates. A 3.5% solution of HiPerFect transfection reagent (QIAGEN) was prepared in serum-free medium and then mixed with the siRNA. The mix was incubated for 30 min at room temperature and then added to the cells. The cell culture medium was replaced the following day and cells were either fixed for immunofluorescence (IF) or harvested for RNA extraction 48-120 h later. The Cy™ 3-labelled siGLO™ cyclophilin B siRNA (Dharmacon) was used to monitor transfection efficiency. Sequences specifying shRNAs against human NR2E1 were cloned in pRetroSuper as previously described12 (link). Lentiviral pLKO-based shRNA targeting mouse NR2E1 (pLKO-shNR2E1.4 and pLKO-shNR2E1.4) were obtained from Sigma (TRCN0000026019 and TRCN0000026030). The sequences of siRNA and shRNAs used are listed in Sup Table 3 . Knockdown of p16INK4a, and CBX7 was achieved using validated shRNA constructs2 (link), 28 (link).
Plko shnr2e1
Manufactured by Merck Group
PLKO-shNR2E1.4 is a laboratory equipment product designed for research purposes. It functions as a plasmid-based short hairpin RNA (shRNA) system, specifically targeting the NR2E1 gene. The core function of this product is to enable the downregulation or knockdown of the NR2E1 gene expression in experimental settings. Further details on the intended use or application of this product are not available.
Automatically generated - may contain errors
2 protocols using plko shnr2e1
1
Transfection of cells with siRNA, miR, and anti-miR
2
Transfection of cells with siRNA, miR, and anti-miR
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
IMR90 cells, HPrEC and NSC were transfected with 20-30 nM siRNA (Qiagen), miR or anti-miR (Ambion) in 96-well or 6-well plates. A 3.5% solution of HiPerFect transfection reagent (QIAGEN) was prepared in serum-free medium and then mixed with the siRNA. The mix was incubated for 30 min at room temperature and then added to the cells. The cell culture medium was replaced the following day and cells were either fixed for immunofluorescence (IF) or harvested for RNA extraction 48-120 h later. The Cy™ 3-labelled siGLO™ cyclophilin B siRNA (Dharmacon) was used to monitor transfection efficiency. Sequences specifying shRNAs against human NR2E1 were cloned in pRetroSuper as previously described12 (link). Lentiviral pLKO-based shRNA targeting mouse NR2E1 (pLKO-shNR2E1.4 and pLKO-shNR2E1.4) were obtained from Sigma (TRCN0000026019 and TRCN0000026030). The sequences of siRNA and shRNAs used are listed in Sup Table 3 . Knockdown of p16INK4a, and CBX7 was achieved using validated shRNA constructs2 (link), 28 (link).
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!